Table 1.

Demographic, biochemical and clinical parameters of the patients with clinically localized PCa (Cohort 1). PSA: Prostate specific antigen; SigPCa: Significant PCa, defined as Gleason score ≥ 7; pT: Pathological primary tumor staging; PI: Perineural invasion; VI: Vascular invasion.

Parameter
Patients [n]	84
Age, years [median (IQR)]	61 (57–66)
PSA levels, ng/mL [median (IQR)]	5.2 (4.2–8.0)
Sig PCa [n (%)]	76 (90.5%)
pT ≥ 3a [n (%)]	59 (70.2%)
PI [n (%)]	72 (85.7%)
VI [n (%)]	8 (9.52%)
Recurrence [n (%)]	35 (41.7%)
Metastasis [n (%)]	0 (0%)